Siren, L.L.C.

GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$4.22B2026 Q3+ $12.3M options (notional, not included)
Positions111
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.47.2%

Siren, L.L.C. reported 111 positions worth $4.22B as of September 30, 2026 (13F filed November 12, 2026). Largest holding: SRRK (10.7%). Biggest move: exit DFTX ($66.8M).

10 / 111 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SRRKScholar Rock$453.0M10.71%9,375,013——-7.8%
▸ 2 KYMRKymera Therapeutics$311.3M7.36%2,784,898——+14.1%
▸ 3 ERASErasca$193.5M4.57%13,197,781———
▸ 4 RVMDRevolution Medicines$174.5M4.12%850,000——-18.7%
▸ 5 ONCBeOne Medicines$170.2M4.02%465,000——+12.4%
▸ 6 TNGXTango Therapeutics$169.3M4.00%6,784,081——-3.1%
▸ 7 MANEVeradermics$160.5M3.79%1,324,299——+5.6%
▸ 8 ARWRArrowhead Pharmaceuticals$149.9M3.54%2,290,476——-32.5%
▸ 9 EWTXEdgewise Therapeutics$113.8M2.69%2,804,179——+7.6%
▸ 10 RYTMRhythm Pharmaceuticals$103.4M2.44%1,086,275——+12.9%

Pro Feature

The remaining 101 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Siren, L.L.C. hold as of Q3 2026?

Siren, L.L.C. reported 111 positions worth $4.22B in its Q3 2026 13F filing. Largest positions: SRRK (10.7%), KYMR (7.4%), ERAS (4.6%), RVMD (4.1%) and ONC (4.0%).

What did Siren, L.L.C. buy in Q3 2026?

New positions: ADRX, ASND, DMRA, YARW and SKHY (18 in all). Added to: TYRA, ARWR, AMLX, ERAS and Entera Bio Ltd (17 in all).

What did Siren, L.L.C. sell in Q3 2026?

Reduced: MANE, ABVX, XENE, KYMR and EWTX (37 in all). Sold out entirely: DFTX, CRNXGBP, COF, SION and ORKA (24 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.